Safety of sipavibart as a pre-exposure prophylaxis for COVID-19 in individuals at high risk of developing severe disease: results of the NOVELLA clinical study conducted in the Russian population

Safety of sipavibart as a pre-exposure prophylaxis for COVID-19 in individuals at high risk of developing severe disease: results of the NOVELLA clinical study conducted in the Russian population

Aim. To evaluate the safety of sipavibart (AZD3152) for pre-exposure prophylaxis of COVID-19 in Russian population of participants at increased risk of developing severe COVID-19. Materials and methods. Randomized, double-blind phase 2 NOVELLA study included adults who had an increased risk of se...

Full description

Saved in:
Bibliographic Details
Main Authors: Daria S. Fomina, Galina N. Salogub, Alexey L. Maslyanskiy, Galina I. Gridneva, Vadim V. Ptushkin, Maria Yu. Sitnikova, Oksana G. Ni, Valeriy V. Breder, Mariia S. Shustova, Nadezhda A. Kravtsova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2024-12-01
Series:Терапевтический архив
Subjects:
covid-19
immunity
passive immunization
monoclonal antibodies
sipavibart
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/656021/171762
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/656021/171762

Similar Items